Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » BTIG Upgrades T2 Biosystems to Buy

BTIG Upgrades T2 Biosystems to Buy

Sep 04, 2015
|
staff reporter

NEW YORK (GenomeWeb) – Investment firm BTIG upgraded shares of molecular diagnostics firm T2 Biosystems, citing the market potential for a bacteria sepsis panel the company has under development.

Analyst Karen Koski upgraded T2 to a Buy rating from Neutral, putting a $16 target price on the company's shares. During late morning trading Friday, T2 stock was trading at $11.19.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Maybe Not the Source

The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.

And Now Machines

According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.

Not Making It Clearer

The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.

Nature Papers Describe Genome Aggregation Database, Mendelian Randomization Method

In Nature this week: the largest known collection of human genetic variants, and more.

What's Popular?

In Business News

  1. Illumina, Genomic Medicine Sweden to Evaluate Sequencing-Based Leukemia Diagnostics

  2. Syapse Raises $30M in Equity Funding

  3. NeoGenomics, Inivata Partner to Commercialize Lung Cancer Liquid Biopsy Test

  4. BioGX, Bosch Healthcare Solutions Partner to Develop Point-of-Care Infectious Disease Tests

  5. Roche Acquires Sequencing Company Stratos Genomics

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.